Question 21
Apatient removed an etonogestre1/etradio1 (Nuvaring) before intercourse, left it out for 4.5 hours, and then re- inserted the ring as directed. The patient did not intend to leave the ring out for thatlong and fears becoming pregnant. Whichcounseling point would be BEST to provide to the patient?
Question 22
An 80-year-oia female patient who has a T-score of 2.7 was recently diagnosed with osteoporosis, and me patients physician wants to initiate an oral medication that will help reduce hip fracture risk Which medication would he MO ST beneficial to recommend?
Question 23
A patient w a past medical history significant for schizopnrenia is being evaluated forlong-acting injectable (LAI) therapy. The patient is taking 3mg of paliperidone daily and has no concerns tor theuse of LAls After completing the initial titration schedule, which maintenance dose of the intramuscular formulation of paliperidone would be BEST for the patient every 4 weeks?
Question 24
A patient completed a genetic test that was requested by a pharmacist. and the results showed that the pattern is a poor metabolizer of CYP2C19 if the patient has history of acute coronary syndrome, which medication should he avoided in the patient's treatment regimen due to a black box warning?
Question 25
A patient has Been using rivastigmine transdermal patch for eight months but missed applying the medication for the last 15 days. Which recommendation would De MO ST appropriate for the pharmacist tor helping the patient resume adherence?
